Translational potential of astrocytes in brain disorders

Progress in Neurobiology

Volumn 144, Issue , 2016, Pages 188-205

  Verkhratsky, Alexei ^a,b,c   Steardo, Luca ^d   Parpura, Vladimir ^e   Montana, Vedrana ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e University of Alabama at Birmingham   (United States)

^f University of Rijeka   (Croatia)

Author keywords

Astrocytes; Morpho functional changes; Pathology; Potential therapeutic targets

Indexed keywords

HEAVY METAL;

ADDICTION; ALEXANDER DISEASE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; AUTISM; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR ACCIDENT; COSTELLO SYNDROME; DEGENERATIVE DISEASE; DOWN SYNDROME; EPILEPSY; GLIA; GLIOMA; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; MOOD DISORDER; NERVOUS SYSTEM INJURY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; ANIMAL; BRAIN DISEASES; METABOLISM; TRANSLATIONAL RESEARCH; TRENDS;

ANIMALS; ASTROCYTES; BRAIN DISEASES; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84948783783     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2015.09.003     Document Type: Review

References (348)

1. Abramov, A.Y., Canevari, L., Duchen, M.R., Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. Neurosci. 23 (2003), 5088–5095.
2. Abramov, A.Y., Canevari, L., Duchen, M.R., Calcium signals induced by amyloid b peptide and their consequences in neurons and astrocytes in culture. Biochim. Biophys. Acta 1742 (2004), 81–87.
3. Agulhon, C., Petravicz, J., McMullen, A.B., Sweger, E.J., Minton, S.K., Taves, S.R., Casper, K.B., Fiacco, T.A., McCarthy, K.D., What is the role of astrocyte calcium in neurophysiology?. Neuron 59 (2008), 932–946.
4. Albrecht, J., Zielinska, M., Norenberg, M.D., Glutamine as a mediator of ammonia neurotoxicity: a critical appraisal. Biochem. Pharmacol. 80 (2010), 1303–1308.
5. Allaman, I., Gavillet, M., Belanger, M., Laroche, T., Viertl, D., Lashuel, H.A., Magistretti, P.J., Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J. Neurosci. 30 (2010), 3326–3338.
6. Alzheimer, A., Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiat. Psych. Gericht. Med. 64 (1907), 146–148.
7. Alzheimer, A., Beiträge zur Kenntnis der pathologischen Neuroglia und ihrer Beziehungen zu den Abbauvorgängen im Nervengewebe. Nissl, F., Alzheimer, A., (eds.) Histologische und histopathologische Arbeiten über die Grosshirnrinde mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskrankheiten, 1910, Gustav Fischer, Jena, 401–562.
8. Anderson, M.A., Ao, Y., Sofroniew, M.V., Heterogeneity of reactive astrocytes. Neurosci. Lett. 565 (2014), 23–29.
9. Armstrong, V., Reichel, C.M., Doti, J.F., Crawford, C.A., McDougall, S.A., Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen. Eur. J. Pharmacol. 488 (2004), 111–115.
10. Aronica, E., Sandau, U.S., Iyer, A., Boison, D., Glial adenosine kinase – a neuropathological marker of the epileptic brain. Neurochem. Int. 63 (2013), 688–695.
11. Aronica, E., Zurolo, E., Iyer, A., de Groot, M., Anink, J., Carbonell, C., van Vliet, E.A., Baayen, J.C., Boison, D., Gorter, J.A., Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia 52 (2011), 1645–1655.
12. Arzberger, T., Krampfl, K., Leimgruber, S., Weindl, A., Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease – an in situ hybridization study. J. Neuropathol. Exp. Neurol. 56 (1997), 440–454.
13. Attwell, D., Buchan, A.M., Charpak, S., Lauritzen, M., Macvicar, B.A., Newman, E.A., Glial and neuronal control of brain blood flow. Nature 468 (2010), 232–243.
14. Baker, D.A., Madayag, A., Kristiansen, L.V., Meador-Woodruff, J.H., Haroutunian, V., Raju, I., Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine. Neuropsychopharmacology 33 (2008), 1760–1772.
15. Banasr, M., Duman, R.S., Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol. Psychiatry 64 (2008), 863–870.
16. Barley, K., Dracheva, S., Byne, W., Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 112 (2009), 54–64.
17. Bauer, D., Gupta, D., Harotunian, V., Meador-Woodruff, J.H., McCullumsmith, R.E., Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr. Res. 104 (2008), 108–120.
18. Bauer, D., Haroutunian, V., Meador-Woodruff, J.H., McCullumsmith, R.E., Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. Schizophr. Res. 117 (2010), 92–98.
19. Beach, T.G., McGeer, E.G., Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex. Brain Res. 463 (1988), 357–361.
20. Beauquis, J., Pavia, P., Pomilio, C., Vinuesa, A., Podlutskaya, N., Galvan, V., Saravia, F., Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease. Exp. Neurol. 239 (2013), 28–37.
21. Beauquis, J., Vinuesa, A., Pomilio, C., Pavia, P., Galvan, V., Saravia, F., Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 24 (2014), 257–269.
22. Bechtholt-Gompf, A.J., Walther, H.V., Adams, M.A., Carlezon, W.A. Jr., Ongur, D., Cohen, B.M., Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 35 (2010), 2049–2059.
23. Bedner, P., Dupper, A., Huttmann, K., Muller, J., Herde, M.K., Dublin, P., Deshpande, T., Schramm, J., Haussler, U., Haas, C.A., Henneberger, C., Theis, M., Steinhauser, C., Astrocyte uncoupling as a cause of human temporal lobe epilepsy. Brain 138 (2015), 1208–1222.
24. Behrens, P.F., Franz, P., Woodman, B., Lindenberg, K.S., Landwehrmeyer, G.B., Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125 (2002), 1908–1922.
25. Bell, R.D., Zlokovic, B.V., Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118 (2009), 103–113.
26. Bendikov, I., Nadri, C., Amar, S., Panizzutti, R., De Miranda, J., Wolosker, H., Agam, G., A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr. Res. 90 (2007), 41–51.
27. Benedetti, B., Matyash, V., Kettenmann, H., Astrocytes control GABAergic inhibition of neurons in the mouse barrel cortex. J. Physiol. 589 (2011), 1159–1172.
28. Bernard, R., Kerman, I.A., Thompson, R.C., Jones, E.G., Bunney, W.E., Barchas, J.D., Schatzberg, A.F., Myers, R.M., Akil, H., Watson, S.J., Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol. Psychiatry 16 (2011), 634–646.
29. Berry, J.D., Shefner, J.M., Conwit, R., Schoenfeld, D., Keroack, M., Felsenstein, D., Krivickas, L., David, W.S., Vriesendorp, F., Pestronk, A., Caress, J.B., Katz, J., Simpson, E., Rosenfeld, J., Pascuzzi, R., Glass, J., Rezania, K., Rothstein, J.D., Greenblatt, D.J., Cudkowicz, M.E., Northeast, A.L.S.C., Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLOS ONE, 8, 2013, e61177.
30. Bertram, L., Lill, C.M., Tanzi, R.E., The genetics of Alzheimer disease: back to the future. Neuron 68 (2010), 270–281.
31. Beschorner, R., Dietz, K., Schauer, N., Mittelbronn, M., Schluesener, H.J., Trautmann, K., Meyermann, R., Simon, P., Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury. Histol. Histopathol. 22 (2007), 515–526.
32. Bigl, M., Bruckner, M.K., Arendt, T., Bigl, V., Eschrich, K., Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J. Neural Transm. 106 (1999), 499–511.
33. Bilsland, L.G., Nirmalananthan, N., Yip, J., Greensmith, L., Duchen, M.R., Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria. J. Neurochem. 107 (2008), 1271–1283.
34. Blass, J.P., Sheu, R.K., Gibson, G.E., Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann. N. Y. Acad. Sci. 903 (2000), 204–221.
35. Bockenhauer, D., Feather, S., Stanescu, H.C., Bandulik, S., Zdebik, A.A., Reichold, M., Tobin, J., Lieberer, E., Sterner, C., Landoure, G., Arora, R., Sirimanna, T., Thompson, D., Cross, J.H., van't Hoff, W., Al Masri, O., Tullus, K., Yeung, S., Anikster, Y., Klootwijk, E., Hubank, M., Dillon, M.J., Heitzmann, D., Arcos-Burgos, M., Knepper, M.A., Dobbie, A., Gahl, W.A., Warth, R., Sheridan, E., Kleta, R., Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N. Engl. J. Med. 360 (2009), 1960–1970.
36. Boison, D., Aronica, E., Comorbidities in neurology: is adenosine the common link?. Neuropharmacology 97 (2015), 18–34.
37. Bordey, A., Sontheimer, H., Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res. 32 (1998), 286–303.
38. Bouzier-Sore, A.K., Pellerin, L., Unraveling the complex metabolic nature of astrocytes. Front. Cell. Neurosci., 7, 2013, 179.
39. Bowers, M.S., Kalivas, P.W., Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration. Eur. J. Neurosci. 17 (2003), 1273–1278.
40. Bowley, M.P., Drevets, W.C., Ongur, D., Price, J.L., Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52 (2002), 404–412.
41. Braun, K., Antemano, R., Helmeke, C., Buchner, M., Poeggel, G., Juvenile separation stress induces rapid region- and layer-specific changes in S100ss- and glial fibrillary acidic protein-immunoreactivity in astrocytes of the rodent medial prefrontal cortex. Neuroscience 160 (2009), 629–638.
42. − cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br. J. Pharmacol. 165 (2012), 20–34.
43. Brissette, C.A., Kees, E.D., Burke, M.M., Gaultney, R.A., Floden, A.M., Watt, J.A., The multifaceted responses of primary human astrocytes and brain microvascular endothelial cells to the Lyme disease spirochete, Borrelia burgdorferi. ASN Neuro 5 (2013), 221–229.
44. Brusilow, S.W., Koehler, R.C., Traystman, R.J., Cooper, A.J., Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 7 (2010), 452–470.
45. Buckingham, S.C., Campbell, S.L., Haas, B.R., Montana, V., Robel, S., Ogunrinu, T., Sontheimer, H., Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17 (2011), 1269–1274.
46. Burda, J.E., Bernstein, A.M., Sofroniew, M.V., Astrocyte roles in traumatic brain injury. Exp. Neurol., 2015, 10.1016/j.expneurol.2015.03.020.
47. Burda, J.E., Sofroniew, M.V., Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81 (2014), 229–248.
48. Burel-Vandenbos, F., Benchetrit, M., Miquel, C., Fontaine, D., Auvergne, R., Lebrun-Frenay, C., Cardot-Leccia, N., Michiels, J.F., Paquis-Flucklinger, V., Virolle, T., EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis. J. Neurooncol. 102 (2011), 171–178.
49. Bushong, E.A., Martone, M.E., Jones, Y.Z., Ellisman, M.H., Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 22 (2002), 183–192.
50. Butterworth, R.F., Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology 53 (2011), 1372–1376.
51. Büttner, A., Weis, S., Neuropathological alterations in drug abusers. The involvement of neurons, glial and vascular systems. Forensic Sci. Med. Pathol. 2 (2006), 115–126.
52. Cassina, P., Cassina, A., Pehar, M., Castellanos, R., Gandelman, M., de Leon, A., Robinson, K.M., Mason, R.P., Beckman, J.S., Barbeito, L., Radi, R., Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 28 (2008), 4115–4122.
53. Cellot, G., Cherubini, E., GABAergic signaling as therapeutic target for autism spectrum disorders. Front. Pediatr., 2, 2014, 70.
54. Chaboub, L.S., Deneen, B., Developmental origins of astrocyte heterogeneity: the final frontier of CNS development. Dev. Neurosci. 34 (2012), 379–388.
55. Chauhan, V.S., Kluttz, J.M., Bost, K.L., Marriott, I., Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis. J. Immunol. 186 (2011), 7255–7263.
56. Chauhan, V.S., Sterka, D.G. Jr., Gray, D.L., Bost, K.L., Marriott, I., Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J. Immunol. 180 (2008), 8241–8249.
57. Cheeran, M.C., Hu, S., Sheng, W.S., Peterson, P.K., Lokensgard, J.R., CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J. Virol. 77 (2003), 4502–4515.
58. Chen, C., Jiang, P., Xue, H., Peterson, S.E., Tran, H.T., McCann, A.E., Parast, M.M., Li, S., Pleasure, D.E., Laurent, L.C., Loring, J.F., Liu, Y., Deng, W., Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat. Commun., 5, 2014, 4430.
59. Chen, P.C., Vargas, M.R., Pani, A.K., Smeyne, R.J., Johnson, D.A., Kan, Y.W., Johnson, J.A., Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 2933–2938.
60. Churchill, M.J., Wesselingh, S.L., Cowley, D., Pardo, C.A., McArthur, J.C., Brew, B.J., Gorry, P.R., Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 66 (2009), 253–258.
61. Cohen, A.L., Colman, H., Glioma biology and molecular markers. Cancer Treat. Res. 163 (2015), 15–30.
62. Cotter, D., Mackay, D., Chana, G., Beasley, C., Landau, S., Everall, I.P., Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 12 (2002), 386–394.
63. Cotter, D., Mackay, D., Landau, S., Kerwin, R., Everall, I., Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 58 (2001), 545–553.
64. Coulter, D.A., Eid, T., Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60 (2012), 1215–1226.
65. Cross, A.J., Slater, P., Reynolds, G.P., Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease. Neurosci. Lett. 67 (1986), 198–202.
66. Cullen, K.M., Halliday, G.M., Chronic alcoholics have substantial glial pathology in the forebrain and diencephalon. Alcohol. Alcohol. Suppl. 2 (1994), 253–257.
67. Curcio, L., Podda, M.V., Leone, L., Piacentini, R., Mastrodonato, A., Cappelletti, P., Sacchi, S., Pollegioni, L., Grassi, C., D'Ascenzo, M., Reduced D-serine levels in the nucleus accumbens of cocaine-treated rats hinder the induction of NMDA receptor-dependent synaptic plasticity. Brain 136 (2013), 1216–1230.
68. Czeh, B., Di Benedetto, B., Antidepressants act directly on astrocytes: evidences and functional consequences. Eur. Neuropsychopharmacol. 23 (2013), 171–185.
69. Czeh, B., Simon, M., Schmelting, B., Hiemke, C., Fuchs, E., Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31 (2006), 1616–1626.
70. de Groot, J.F., Liu, T.J., Fuller, G., Yung, W.K., The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 65 (2005), 1934–1940.
71. DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J., Kouri, N., Wojtas, A., Sengdy, P., Hsiung, G.Y., Karydas, A., Seeley, W.W., Josephs, K.A., Coppola, G., Geschwind, D.H., Wszolek, Z.K., Feldman, H., Knopman, D.S., Petersen, R.C., Miller, B.L., Dickson, D.W., Boylan, K.B., Graff-Radford, N.R., Rademakers, R., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 (2011), 245–256.
72. Demarque, M., Villeneuve, N., Manent, J.B., Becq, H., Represa, A., Ben-Ari, Y., Aniksztejn, L., Glutamate transporters prevent the generation of seizures in the developing rat neocortex. J. Neurosci. 24 (2004), 3289–3294.
73. Deng, H.X., Chen, W., Hong, S.T., Boycott, K.M., Gorrie, G.H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., Jiang, H., Hirano, M., Rampersaud, E., Jansen, G.H., Donkervoort, S., Bigio, E.H., Brooks, B.R., Ajroud, K., Sufit, R.L., Haines, J.L., Mugnaini, E., Pericak-Vance, M.A., Siddique, T., Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477 (2011), 211–215.
74. DeWitt, D.A., Perry, G., Cohen, M., Doller, C., Silver, J., Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149 (1998), 329–340.
75. Di Giorgio, F.P., Boulting, G.L., Bobrowicz, S., Eggan, K.C., Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3 (2008), 637–648.
76. Di Giorgio, F.P., Carrasco, M.A., Siao, M.C., Maniatis, T., Eggan, K., Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10 (2007), 608–614.
77. ir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J. Neurosci. 27 (2007), 11354–11365.
78. Dong, L., Li, B., Verkhratsky, A., Peng, L., Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine. Psychopharmacology (Berl.) 232 (2015), 2827–2835.
79. Dotevall, L., Rosengren, L.E., Hagberg, L., Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAP) in Lyme neuroborreliosis. Infection 24 (1996), 125–129.
80. Dringen, R., Gutterer, J.M., Hirrlinger, J., Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267 (2000), 4912–4916.
81. Dringen, R., Hirrlinger, J., Glutathione pathways in the brain. Biol. Chem. 384 (2003), 505–516.
82. Eid, T., Tu, N., Lee, T.S., Lai, J.C., Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem. Int. 63 (2013), 670–681.
83. Ekblom, J., Jossan, S.S., Bergstrom, M., Oreland, L., Walum, E., Aquilonius, S.M., Monoamine oxidase-B in astrocytes. Glia 8 (1993), 122–132.
84. Eroglu, C., Barres, B.A., Regulation of synaptic connectivity by glia. Nature 468 (2010), 223–231.
85. Esen, N., Shuffield, D., Syed, M.M., Kielian, T., Modulation of connexin expression and gap junction communication in astrocytes by the gram-positive bacterium S. aureus. Glia 55 (2007), 104–117.
86. Esen, N., Tanga, F.Y., DeLeo, J.A., Kielian, T., Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J. Neurochem. 88 (2004), 746–758.
87. Faideau, M., Kim, J., Cormier, K., Gilmore, R., Welch, M., Auregan, G., Dufour, N., Guillermier, M., Brouillet, E., Hantraye, P., Deglon, N., Ferrante, R.J., Bonvento, G., In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum. Mol. Genet. 19 (2010), 3053–3067.
88. Falkai, P., Bogerts, B., Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiatry Neurol. Sci. 236 (1986), 154–161.
89. Farkas, E., Luiten, P.G., Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64 (2001), 575–611.
90. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., Lee, S., Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 62 (2008), 501–507.
91. Fattore, L., Puddu, M.C., Picciau, S., Cappai, A., Fratta, W., Serra, G.P., Spiga, S., Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience 110 (2002), 1–6.
92. Felipo, V., Hepatic encephalopathy: effects of liver failure on brain function. Nat. Rev. Neurosci. 14 (2013), 851–858.
93. Ferraiuolo, L., Higginbottom, A., Heath, P.R., Barber, S., Greenald, D., Kirby, J., Shaw, P.J., Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134 (2011), 2627–2641.
94. Forno, L.S., DeLanney, L.E., Irwin, I., Di Monte, D., Langston, J.W., Astrocytes and Parkinson's disease. Prog. Brain Res. 94 (1992), 429–436.
95. Fowler, C.J., Wiberg, A., Oreland, L., Marcusson, J., Winblad, B., The effect of age on the activity and molecular properties of human brain monoamine oxidase. J. Neural. Transm. 49 (1980), 1–20.
96. Fowler, J.S., Volkow, N.D., Wang, G.J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A.P., Warner, D., Zezulkova, I., Cilento, R., Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996), 733–736.
97. Franke, H., Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats. Acta Histochem. 97 (1995), 263–271.
98. Friend, D.M., Keefe, K.A., Glial reactivity in resistance to methamphetamine-induced neurotoxicity. J. Neurochem. 125 (2013), 566–574.
99. Furman, J.L., Sama, D.M., Gant, J.C., Beckett, T.L., Murphy, M.P., Bachstetter, A.D., Van Eldik, L.J., Norris, C.M., Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. J. Neurosci. 32 (2012), 16129–16140.
100. Furnari, F.B., Fenton, T., Bachoo, R.M., Mukasa, A., Stommel, J.M., Stegh, A., Hahn, W.C., Ligon, K.L., Louis, D.N., Brennan, C., Chin, L., DePinho, R.A., Cavenee, W.K., Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21 (2007), 2683–2710.
101. Giaume, C., Kirchhoff, F., Matute, C., Reichenbach, A., Verkhratsky, A., Glia: the fulcrum of brain diseases. Cell Death Differ. 14 (2007), 1324–1335.
102. Giovedi, S., Corradi, A., Fassio, A., Benfenati, F., Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins. Front. Pediatr., 2, 2014, 94.
103. Gipson, C.D., Reissner, K.J., Kupchik, Y.M., Smith, A.C., Stankeviciute, N., Hensley-Simon, M.E., Kalivas, P.W., Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9124–9129.
104. Gleichman, A.J., Carmichael, S.T., Astrocytic therapies for neuronal repair in stroke. Neurosci. Lett. 565 (2014), 47–52.
105. Gorg, B., Morwinsky, A., Keitel, V., Qvartskhava, N., Schror, K., Haussinger, D., Ammonia triggers exocytotic release of L-glutamate from cultured rat astrocytes. Glia 58 (2010), 691–705.
106. Gray, L.R., Turville, S.G., Hitchen, T.L., Cheng, W.J., Ellett, A.M., Salimi, H., Roche, M.J., Wesselingh, S.L., Gorry, P.R., Churchill, M.J., HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles. PLOS ONE, 9, 2014, e90620.
107. Gray, M., The role of astrocytes in Huntington's disease. Parpura, V., Verkhratsky, A., (eds.) Pathological Potentual of Neuroglia. Possible New Targets for Medical Intervention, 2014, Springer, New York/Heidelberg/Dordrecht/London, 213–229.
108. Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, C.L. 3rd, Araoz, C., Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 7611–7615.
109. Grolla, A.A., Sim, J.A., Lim, D., Rodriguez, J.J., Genazzani, A.A., Verkhratsky, A., Amyloid-b and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions. Cell Death Dis., 4, 2013, e623.
110. Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.H., Iwasato, T., Itohara, S., Li, X.J., Mody, I., Heintz, N., Yang, X.W., Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46 (2005), 433–444.
111. Guilarte, T.R., Nihei, M.K., McGlothan, J.L., Howard, A.S., Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 122 (2003), 499–513.
112. Haack, N., Dublin, P., Rose, C.R., Dysbalance of astrocyte calcium under hyperammonemic conditions. PLOS ONE, 9, 2014, e105832.
113. Haberle, J., Shahbeck, N., Ibrahim, K., Hoffmann, G.F., Ben-Omran, T., Natural course of glutamine synthetase deficiency in a 3 year old patient. Mol. Genet. Metab. 103 (2011), 89–91.
114. Haidet-Phillips, A.M., Hester, M.E., Miranda, C.J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M.J., Foust, K.D., Rao, M., Eagle, A., Kammesheidt, A., Christensen, A., Mendell, J.R., Burghes, A.H., Kaspar, B.K., Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29 (2011), 824–828.
115. Hardiman, O., Management of respiratory symptoms in ALS. J. Neurol. 258 (2011), 359–365.
116. Harvey, B.K., Airavaara, M., Hinzman, J., Wires, E.M., Chiocco, M.J., Howard, D.B., Shen, H., Gerhardt, G., Hoffer, B.J., Wang, Y., Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS ONE, 6, 2011, e22135.
117. Hazell, A.S., Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy. Neurochem. Int. 55 (2009), 129–135.
118. Hedreen, J.C., Peyser, C.E., Folstein, S.E., Ross, C.A., Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133 (1991), 257–261.
119. Heneka, M.T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., Van Leuven, F., Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J. Neuroinflamm., 2, 2005, 22.
120. Herman, M., Ciancanelli, M., Ou, Y.H., Lorenzo, L., Klaudel-Dreszler, M., Pauwels, E., Sancho-Shimizu, V., Perez de Diego, R., Abhyankar, A., Israelsson, E., Guo, Y., Cardon, A., Rozenberg, F., Lebon, P., Tardieu, M., Heropolitanska-Pliszka, E., Chaussabel, D., White, M.A., Abel, L., Zhang, S.Y., Casanova, J.L., Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209 (2012), 1567–1582.
121. ir4.1 are associated with subgroups of patients with temporal lobe epilepsy. Epilepsy Res. 88 (2010), 55–64.
122. Hildebrand, J., Lecaille, C., Perennes, J., Delattre, J.Y., Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65 (2005), 212–215.
123. Hinterkeuser, S., Schroder, W., Hager, G., Seifert, G., Blumcke, I., Elger, C.E., Schramm, J., Steinhauser, C., Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur. J. Neurosci. 12 (2000), 2087–2096.
124. Holtze, M., Saetre, P., Engberg, G., Schwieler, L., Werge, T., Andreassen, O.A., Hall, H., Terenius, L., Agartz, I., Jonsson, E.G., Schalling, M., Erhardt, S., Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. J. Psychiatry Neurosci. 37 (2012), 53–57.
125. Hsiao, H.Y., Chen, Y.C., Huang, C.H., Chen, C.C., Hsu, Y.H., Chen, H.M., Chiu, F.L., Kuo, H.C., Chang, C., Chern, Y., Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann. Neurol. 78 (2015), 178–192.
126. Huang, C., Han, X., Li, X., Lam, E., Peng, W., Lou, N., Torres, A., Yang, M., Garre, J.M., Tian, G.F., Bennett, M.V., Nedergaard, M., Takano, T., Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci. 32 (2012), 3333–3338.
127. Iadecola, C., Nedergaard, M., Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10 (2007), 1369–1376.
128. Iovino, F., Orihuela, C.J., Moorlag, H.E., Molema, G., Bijlsma, J.J., Interactions between blood–borne Streptococcus pneumoniae and the blood–brain barrier preceding meningitis. PLOS ONE, 8, 2013, e68408.
129. Iuvone, T., Esposito, G., De Filippis, D., Bisogno, T., Petrosino, S., Scuderi, C., Di Marzo, V., Steardo, L., Endocannabinoid Research, G., Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. J. Mol. Med. (Berl.) 85 (2007), 1379–1392.
130. Jacobs, S., Doering, L.C., Astrocytes prevent abnormal neuronal development in the fragile × mouse. J. Neurosci. 30 (2010), 4508–4514.
131. Jacobs, S., Nathwani, M., Doering, L.C., Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci., 11, 2010, 132.
132. Joseph, S.B., Arrildt, K.T., Sturdevant, C.B., Swanstrom, R., HIV-1 target cells in the CNS. J. Neurovirol. 21 (2015), 276–289.
133. Jovcevska, I., Kocevar, N., Komel, R., Glioma and glioblastoma – how much do we (not) know?. Mol. Clin. Oncol. 1 (2013), 935–941.
134. Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J., Vande Velde, C., Bouchard, J.P., Lacomblez, L., Pochigaeva, K., Salachas, F., Pradat, P.F., Camu, W., Meininger, V., Dupre, N., Rouleau, G.A., TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40 (2008), 572–574.
135. Kanemaru, K., Kubota, J., Sekiya, H., Hirose, K., Okubo, Y., Iino, M., Calcium-dependent N-cadherin up-regulation mediates reactive astrogliosis and neuroprotection after brain injury. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 11612–11617.
136. Karlsen, A.S., Pakkenberg, B., Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with Down syndrome – a stereological study. Cereb. Cortex 21 (2011), 2519–2524.
137. Karlsson, R.M., Tanaka, K., Heilig, M., Holmes, A., Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol. Psychiatry 64 (2008), 810–814.
138. Karlsson, R.M., Tanaka, K., Saksida, L.M., Bussey, T.J., Heilig, M., Holmes, A., Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology 34 (2009), 1578–1589.
139. Kelamangalath, L., Wagner, J.J., D-Serine treatment reduces cocaine-primed reinstatement in rats following extended access to cocaine self-administration. Neuroscience 169 (2010), 1127–1135.
140. Kelly, T., Kafitz, K.W., Roderigo, C., Rose, C.R., Ammonium-evoked alterations in intracellular sodium and pH reduce glial glutamate transport activity. Glia 57 (2009), 921–934.
141. Kelly, T., Rose, C.R., Ammonium influx pathways into astrocytes and neurones of hippocampal slices. J. Neurochem. 115 (2010), 1123–1136.
142. Kettenmann, H., Hanisch, U.K., Noda, M., Verkhratsky, A., Physiology of microglia. Physiol. Rev. 91 (2011), 461–553.
143. Kettenmann, H., Ransom, B.R., (eds.) Neuroglia, 2013, Oxford University Press, Oxford.
144. Kidd, S.A., Lachiewicz, A., Barbouth, D., Blitz, R.K., Delahunty, C., McBrien, D., Visootsak, J., Berry-Kravis, E., Fragile X syndrome: a review of associated medical problems. Pediatrics 134 (2014), 995–1005.
145. Kimura, N., Okabayashi, S., Ono, F., Dynein dysfunction disrupts beta-amyloid clearance in astrocytes through endocytic disturbances. Neuroreport 25 (2014), 514–520.
146. Kirischuk, S., Parpura, V., Verkhratsky, A., Sodium dynamics: another key to astroglial excitability?. Trends Neurosci. 35 (2012), 497–506.
147. Knackstedt, L.A., Melendez, R.I., Kalivas, P.W., Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol. Psychiatry 67 (2010), 81–84.
148. Koss, W.A., Sadowski, R.N., Sherrill, L.K., Gulley, J.M., Juraska, J.M., Effects of ethanol during adolescence on the number of neurons and glia in the medial prefrontal cortex and basolateral amygdala of adult male and female rats. Brain Res. 1466 (2012), 24–32.
149. Kraepelin, E., Psychiatrie: Ein Lehrbuch fuer Studierende und Arzte. 1910, Johann Ambrosius Barth, Leipzig.
150. Kraft, A.W., Hu, X., Yoon, H., Yan, P., Xiao, Q., Wang, Y., Gil, S.C., Brown, J., Wilhelmsson, U., Restivo, J.L., Cirrito, J.R., Holtzman, D.M., Kim, J., Pekny, M., Lee, J.M., Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 27 (2013), 187–198.
151. Krencik, R., Hokanson, K.C., Narayan, A.R., Dvornik, J., Rooney, G.E., Rauen, K.A., Weiss, L.A., Rowitch, D.H., Ullian, E.M., Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci. Transl. Med., 7, 2015 286ra266.
152. Kuchibhotla, K.V., Lattarulo, C.R., Hyman, B.T., Bacskai, B.J., Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323 (2009), 1211–1215.
153. Kulijewicz-Nawrot, M., Verkhratsky, A., Chvatal, A., Sykova, E., Rodriguez, J.J., Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J. Anat. 221 (2012), 252–262.
154. Kurzwelly, D., Herrlinger, U., Simon, M., Seizures in patients with low-grade gliomas – incidence, pathogenesis, surgical management, and pharmacotherapy. Adv. Tech. Stand. Neurosurg. 35 (2010), 81–111.
155. Kwiatkowski, T.J. Jr., Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T., Valdmanis, P., Rouleau, G.A., Hosler, B.A., Cortelli, P., de Jong, P.J., Yoshinaga, Y., Haines, J.L., Pericak-Vance, M.A., Yan, J., Ticozzi, N., Siddique, T., McKenna-Yasek, D., Sapp, P.C., Horvitz, H.R., Landers, J.E., Brown, R.H. Jr., Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323 (2009), 1205–1208.
156. Labrie, V., Fukumura, R., Rastogi, A., Fick, L.J., Wang, W., Boutros, P.C., Kennedy, J.L., Semeralul, M.O., Lee, F.H., Baker, G.B., Belsham, D.D., Barger, S.W., Gondo, Y., Wong, A.H., Roder, J.C., Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum. Mol. Genet. 18 (2009), 3227–3243.
157. Laruelle, M., Schizophrenia: from dopaminergic to glutamatergic interventions. Curr. Opin. Pharmacol. 14 (2014), 97–102.
158. Lauritzen, M., Dreier, J.P., Fabricius, M., Hartings, J.A., Graf, R., Strong, A.J., Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J. Cereb. Blood Flow Metab. 31 (2011), 17–35.
159. Lee, H.J., Suk, J.E., Patrick, C., Bae, E.J., Cho, J.H., Rho, S., Hwang, D., Masliah, E., Lee, S.J., Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285 (2010), 9262–9272.
160. Lee, J., Borboa, A.K., Baird, A., Eliceiri, B.P., Non-invasive quantification of brain tumor-induced astrogliosis. BMC Neurosci., 12, 2011, 9.
161. 2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model. Neurobiol. Dis. 58 (2013), 192–199.
162. Lepore, A.C., Rauck, B., Dejea, C., Pardo, A.C., Rao, M.S., Rothstein, J.D., Maragakis, N.J., Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 11 (2008), 1294–1301.
163. Li, T., Lan, J.Q., Boison, D., Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice. Neuron Glia Biol. 4 (2008), 91–99.
164. Li, T., Lytle, N., Lan, J.Q., Sandau, U.S., Boison, D., Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?. Glia 60 (2012), 83–95.
165. Li, T., Quan Lan, J., Fredholm, B.B., Simon, R.P., Boison, D., Adenosine dysfunction in astrogliosis: cause for seizure generation?. Neuron Glia Biol. 3 (2007), 353–366.
166. Li, Y., Sattler, R., Yang, E.J., Nunes, A., Ayukawa, Y., Akhtar, S., Ji, G., Zhang, P.W., Rothstein, J.D., Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression. Neuropharmacology 60 (2011), 1168–1175.
167. 2+ signalling and up-regulates expression of TRPC1 gene in astrocytes in primary cultures and in the in vivo brain. Neurochem. Res. 39 (2014), 2127–2135.
168. Liang, W.S., Reiman, E.M., Valla, J., Dunckley, T., Beach, T.G., Grover, A., Niedzielko, T.L., Schneider, L.E., Mastroeni, D., Caselli, R., Kukull, W., Morris, J.C., Hulette, C.M., Schmechel, D., Rogers, J., Stephan, D.A., Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 4441–4446.
169. Lim, D., Ronco, V., Grolla, A.A., Verkhratsky, A., Genazzani, A.A., Glial calcium signalling in Alzheimer's disease. Rev. Physiol. Biochem. Pharmacol. 167 (2014), 45–65.
170. Liu, X., Chauhan, V.S., Young, A.B., Marriott, I., NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae. Glia 58 (2010), 839–847.
171. Liu, Z., Song, D., Yan, E., Verkhratsky, A., Peng, L., Chronic treatment with anti-bipolar drugs suppresses glutamate release from astroglial cultures. Amino Acids 47 (2015), 1045–1051.
172. Lothman, E.W., Somjen, G.G., Functions of primary afferents and responses of extracellular K+ during spinal epileptiform seizures. Electroencephalogr. Clin. Neurophysiol. 41 (1976), 253–267.
173. Lynam, L.M., Lyons, M.K., Drazkowski, J.F., Sirven, J.I., Noe, K.H., Zimmerman, R.S., Wilkens, J.A., Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin. Neurol. Neurosurg. 109 (2007), 634–638.
174. Ma, T.M., Abazyan, S., Abazyan, B., Nomura, J., Yang, C., Seshadri, S., Sawa, A., Snyder, S.H., Pletnikov, M.V., Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion. Mol. Psychiatry 18 (2013), 557–567.
175. Mahy, N., Andres, N., Andrade, C., Saura, J., Age-related changes of MAO-A and -B distribution in human and mouse brain. Neurobiology (Bp) 8 (2000), 47–54.
176. Makar, T.K., Nedergaard, M., Preuss, A., Gelbard, A.S., Perumal, A.S., Cooper, A.J., Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62 (1994), 45–53.
177. Malarkey, E.B., Parpura, V., Mechanisms of glutamate release from astrocytes. Neurochem. Int. 52 (2008), 142–154.
178. Mallajosyula, J.K., Kaur, D., Chinta, S.J., Rajagopalan, S., Rane, A., Nicholls, D.G., Di Monte, D.A., Macarthur, H., Andersen, J.K., MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS ONE, 3, 2008, e1616.
179. Mandel, S., Grunblatt, E., Riederer, P., Youdim, M.B., Genes and oxidative stress in parkinsonism: cDNA microarray studies. Adv. Neurol. 91 (2003), 123–132.
180. Marchetto, M.C., Muotri, A.R., Mu, Y., Smith, A.M., Cezar, G.G., Gage, F.H., Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3 (2008), 649–657.
181. Marcus, H.J., Carpenter, K.L., Price, S.J., Hutchinson, P.J., In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J. Neurooncol. 97 (2010), 11–23.
182. Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., Komure, O., Matsuura, S., Kobatake, K., Morimoto, N., Abe, K., Suzuki, N., Aoki, M., Kawata, A., Hirai, T., Kato, T., Ogasawara, K., Hirano, A., Takumi, T., Kusaka, H., Hagiwara, K., Kaji, R., Kawakami, H., Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465 (2010), 223–226.
183. Masino, S.A., Li, T., Theofilas, P., Sandau, U.S., Ruskin, D.N., Fredholm, B.B., Geiger, J.D., Aronica, E., Boison, D., A ketogenic diet suppresses seizures in mice through adenosine A(1) receptors. J. Clin. Invest. 121 (2011), 2679–2683.
184. Matos, M., Augusto, E., Oliveira, C.R., Agostinho, P., Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 156 (2008), 898–910.
185. Matyash, V., Kettenmann, H., Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 63 (2010), 2–10.
186. McGeer, P.L., McGeer, E.G., Glial reactions in Parkinson's disease. Mov. Disord. 23 (2008), 474–483.
187. McGinnis, W.R., Oxidative stress in autism. Altern. Ther. Health Med. 10 (2004), 22–36 quiz 37, 92.
188. Meador-Woodruff, J.H., Clinton, S.M., Beneyto, M., McCullumsmith, R.E., Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann. N. Y. Acad. Sci. 1003 (2003), 75–93.
189. Meda, L., Baron, P., Scarlato, G., Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins. Neurobiol. Aging 22 (2001), 885–893.
190. Meredith, G.E., Sonsalla, P.K., Chesselet, M.F., Animal models of Parkinson's disease progression. Acta Neuropathol. 115 (2008), 385–398.
191. Messing, A., Brenner, M., Feany, M.B., Nedergaard, M., Goldman, J.E., Alexander disease. J. Neurosci. 32 (2012), 5017–5023.
192. Miguel-Hidalgo, J., Shoyama, Y., Wanzo, V., Infusion of gliotoxins or a gap junction blocker in the prelimbic cortex increases alcohol preference in Wistar rats. J. Psychopharmacol. 23 (2009), 550–557.
193. Miguel-Hidalgo, J.J., Lower packing density of glial fibrillary acidic protein-immunoreactive astrocytes in the prelimbic cortex of alcohol-naive and alcohol-drinking alcohol-preferring rats as compared with alcohol-nonpreferring and Wistar rats. Alcohol. Clin. Exp. Res. 29 (2005), 766–772.
194. Miguel-Hidalgo, J.J., The role of glial cells in drug abuse. Curr. Drug Abuse Rev. 2 (2009), 76–82.
195. Miguel-Hidalgo, J.J., Overholser, J.C., Meltzer, H.Y., Stockmeier, C.A., Rajkowska, G., Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence. Alcohol. Clin. Exp. Res. 30 (2006), 1845–1855.
196. Miguel-Hidalgo, J.J., Wei, J., Andrew, M., Overholser, J.C., Jurjus, G., Stockmeier, C.A., Rajkowska, G., Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol. Psychiatry 52 (2002), 1121–1133.
197. Mirza, B., Hadberg, H., Thomsen, P., Moos, T., The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95 (2000), 425–432.
198. Molsa, P.K., Marttila, R.J., Rinne, U.K., Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol. Scand. 74 (1986), 103–107.
199. Montana, V., Verkhratsky, A., Parpura, V., Pathological role for exocytotic glutamate release from astrocytes in hepatic encephalopathy. Curr. Neuropharmacol. 12 (2014), 324–333.
200. Moody, W.J., Futamachi, K.J., Prince, D.A., Extracellular potassium activity during epileptogenesis. Exp. Neurol. 42 (1974), 248–263.
201. Moon, J.H., Kwon, S., Jun, E.K., Kim, A., Whang, K.Y., Kim, H., Oh, S., Yoon, B.S., You, S., Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem. Biophys. Res. Commun. 412 (2011), 175–181.
202. Mosconi, L., Pupi, A., De Leon, M.J., Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann. N. Y. Acad. Sci. 1147 (2008), 180–195.
203. Moussawi, K., Riegel, A., Nair, S., Kalivas, P.W., Extracellular glutamate: functional compartments operate in different concentration ranges. Front. Syst. Neurosci., 5, 2011, 94.
204. Mrak, R.E., Griffin, W.S., Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005), 349–354.
205. Nagai, M., Re, D.B., Nagata, T., Chalazonitis, A., Jessell, T.M., Wichterle, H., Przedborski, S., Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10 (2007), 615–622.
206. Narasipura, S.D., Kim, S., Al-Harthi, L., Epigenetic regulation of HIV-1 latency in astrocytes. J. Virol. 88 (2014), 3031–3038.
207. Nedergaard, M., Spreading depression as a contributor to ischemic brain damage. Adv. Neurol. 71 (1996), 75–83 discussion 83-74.
208. Nedergaard, M., Ransom, B., Goldman, S.A., New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26 (2003), 523–530.
209. Nedergaard, M., Rodriguez, J.J., Verkhratsky, A., Glial calcium and diseases of the nervous system. Cell Calcium 47 (2010), 140–149.
210. Norenberg, M.D., The role of astrocytes in hepatic encephalopathy. Neurochem. Pathol. 6 (1987), 13–33.
211. Obara-Michlewska, M., Ruszkiewicz, J., Zielinska, M., Verkhratsky, A., Albrecht, J., Astroglial NMDA receptors inhibit expression of K4.1 channels in glutamate-overexposed astrocytes in vitro and in the brain of rats with acute liver failure. Neurochem. Int. 88 (2015), 20–25.
212. Oberheim, N.A., Goldman, S.A., Nedergaard, M., Heterogeneity of astrocytic form and function. Methods Mol. Biol. 814 (2012), 23–45.
213. Oberndorfer, S., Schmal, T., Lahrmann, H., Urbanits, S., Lindner, K., Grisold, W., The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien. Klin. Wochenschr. 114 (2002), 911–916.
214. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y., LaFerla, F.M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Ab and synaptic dysfunction. Neuron 39 (2003), 409–421.
215. Oehmichen, M., Meissner, C., Reiter, A., Birkholz, M., Neuropathology in non-human immunodeficiency virus-infected drug addicts: hypoxic brain damage after chronic intravenous drug abuse. Acta Neuropathol. 91 (1996), 642–646.
216. Ohnuma, T., Tessler, S., Arai, H., Faull, R.L., McKenna, P.J., Emson, P.C., Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Brain Res. Mol. Brain Res. 85 (2000), 24–31.
217. Olabarria, M., Noristani, H.N., Verkhratsky, A., Rodriguez, J.J., Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 58 (2010), 831–838.
218. Olabarria, M., Noristani, H.N., Verkhratsky, A., Rodriguez, J.J., Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Mol. Neurodegener., 6, 2011, 55.
219. Ongur, D., Drevets, W.C., Price, J.L., Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 13290–13295.
220. Orellana, J.A., Saez, J.C., Bennett, M.V., Berman, J.W., Morgello, S., Eugenin, E.A., HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. J. Neurochem. 128 (2014), 752–763.
221. Ortinski, P.I., Dong, J., Mungenast, A., Yue, C., Takano, H., Watson, D.J., Haydon, P.G., Coulter, D.A., Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci. 13 (2010), 584–591.
222. Papadeas, S.T., Kraig, S.E., O'Banion, C., Lepore, A.C., Maragakis, N.J., Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 17803–17808.
223. Park, D.M., Rich, J.N., Biology of glioma cancer stem cells. Mol. Cells 28 (2009), 7–12.
224. Parpura-Gill, A., Beitz, D., Uemura, E., The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 754 (1997), 65–71.
225. 2+ sources for the exocytotic release of glutamate from astrocytes. Biochim. Biophys. Acta 1813 (2011), 984–991.
226. Parpura, V., Heneka, M.T., Montana, V., Oliet, S.H., Schousboe, A., Haydon, P.G., Stout, R.F. Jr., Spray, D.C., Reichenbach, A., Pannicke, T., Pekny, M., Pekna, M., Zorec, R., Verkhratsky, A., Glial cells in (patho)physiology. J. Neurochem. 121 (2012), 4–27.
227. Parpura, V., Verkhratsky, A., The astrocyte excitability brief: from receptors to gliotransmission. Neurochem. Int. 61 (2012), 610–621.
228. + signalling. Transl. Neurosci. 3 (2012), 334–344.
229. Parpura, V., Verkhratsky, A., Astroglial amino acid-based transmitter receptors. Amino Acids 44 (2013), 1151–1158.
230. Pekny, M., Wilhelmsson, U., Pekna, M., The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 565C (2014), 30–38.
231. Perides, G., Tanner-Brown, L.M., Eskildsen, M.A., Klempner, M.S., Borrelia burgdorferi induces matrix metalloproteinases by neural cultures. J. Neurosci. Res. 58 (1999), 779–790.
232. Phatnani, H.P., Guarnieri, P., Friedman, B.A., Carrasco, M.A., Muratet, M., O'Keeffe, S., Nwakeze, C., Pauli-Behn, F., Newberry, K.M., Meadows, S.K., Tapia, J.C., Myers, R.M., Maniatis, T., Intricate interplay between astrocytes and motor neurons in ALS. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E756–E765.
233. Popoli, M., Yan, Z., McEwen, B.S., Sanacora, G., The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 13 (2012), 22–37.
234. Proschel, C., Stripay, J.L., Shih, C.H., Munger, J.C., Noble, M.D., Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons. EMBO Mol. Med. 6 (2014), 504–518.
235. Prust, M., Wang, J., Morizono, H., Messing, A., Brenner, M., Gordon, E., Hartka, T., Sokohl, A., Schiffmann, R., Gordish-Dressman, H., Albin, R., Amartino, H., Brockman, K., Dinopoulos, A., Dotti, M.T., Fain, D., Fernandez, R., Ferreira, J., Fleming, J., Gill, D., Griebel, M., Heilstedt, H., Kaplan, P., Lewis, D., Nakagawa, M., Pedersen, R., Reddy, A., Sawaishi, Y., Schneider, M., Sherr, E., Takiyama, Y., Wakabayashi, K., Gorospe, J.R., Vanderver, A., GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology 77 (2011), 1287–1294.
236. Qrunfleh, A.M., Alazizi, A., Sari, Y., Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats. J. Psychopharmacol. 27 (2013), 541–549.
237. Quaak, I., Brouns, M.R., Van de Bor, M., The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact. Int. J. Environ. Res. Public Health 10 (2013), 3384–3408.
238. Rajkowska, G., Miguel-Hidalgo, J.J., Makkos, Z., Meltzer, H., Overholser, J., Stockmeier, C., Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 57 (2002), 127–138.
239. Rajkowska, G., Miguel-Hidalgo, J.J., Wei, J., Dilley, G., Pittman, S.D., Meltzer, H.Y., Overholser, J.C., Roth, B.L., Stockmeier, C.A., Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45 (1999), 1085–1098.
240. Rajkowska, G., Stockmeier, C.A., Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets 14 (2013), 1225–1236.
241. Rangroo Thrane, V., Thrane, A.S., Wang, F., Cotrina, M.L., Smith, N.A., Chen, M., Xu, Q., Kang, N., Fujita, T., Nagelhus, E.A., Nedergaard, M., Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering. Nat. Med. 19 (2013), 1643–1648.
242. Rao, V.L., Baskaya, M.K., Dogan, A., Rothstein, J.D., Dempsey, R.J., Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J. Neurochem. 70 (1998), 2020–2027.
243. Rao, V.L., Dogan, A., Todd, K.G., Bowen, K.K., Kim, B.T., Rothstein, J.D., Dempsey, R.J., Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Neurosci. 21 (2001), 1876–1883.
244. Raore, B., Schniederjan, M., Prabhu, R., Brat, D.J., Shu, H.K., Olson, J.J., Metastasis infiltration: an investigation of the postoperative brain-tumor interface. Int. J. Radiat. Oncol. Biol. Phys. 81 (2011), 1075–1080.
245. Rappold, P.M., Tieu, K., Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 7 (2010), 413–423.
246. Reinert, L.S., Harder, L., Holm, C.K., Iversen, M.B., Horan, K.A., Dagnaes-Hansen, F., Ulhoi, B.P., Holm, T.H., Mogensen, T.H., Owens, T., Nyengaard, J.R., Thomsen, A.R., Paludan, S.R., TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122 (2012), 1368–1376.
247. Reissner, K.J., Kalivas, P.W., Using glutamate homeostasis as a target for treating addictive disorders. Behav. Pharmacol. 21 (2010), 514–522.
248. Reissner, K.J., Kalivas, P.W., Emerging roles for glial pathology in addiction. Parpura, V., Verkhratsky, A., (eds.) Pathological Potential of Neuroglia: Possible New Targets for Medical Intervention, 2014, Springer, New York/Heidelberg/Dordrecht/London, 397–418.
249. Ren, J., Song, D., Bai, Q., Verkhratsky, A., Peng, L., Fluoxetine induces alkalinization of astroglial cytosol through stimulation of sodium-hydrogen exchanger 1: dissection of intracellular signaling pathways. Front. Cell. Neurosci., 9, 2015, 61.
250. Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van Swieten, J.C., Myllykangas, L., Kalimo, H., Paetau, A., Abramzon, Y., Remes, A.M., Kaganovich, A., Scholz, S.W., Duckworth, J., Ding, J., Harmer, D.W., Hernandez, D.G., Johnson, J.O., Mok, K., Ryten, M., Trabzuni, D., Guerreiro, R.J., Orrell, R.W., Neal, J., Murray, A., Pearson, J., Jansen, I.E., Sondervan, D., Seelaar, H., Blake, D., Young, K., Halliwell, N., Callister, J.B., Toulson, G., Richardson, A., Gerhard, A., Snowden, J., Mann, D., Neary, D., Nalls, M.A., Peuralinna, T., Jansson, L., Isoviita, V.M., Kaivorinne, A.L., Holtta-Vuori, M., Ikonen, E., Sulkava, R., Benatar, M., Wuu, J., Chio, A., Restagno, G., Borghero, G., Sabatelli, M., Consortium, I., Heckerman, D., Rogaeva, E., Zinman, L., Rothstein, J.D., Sendtner, M., Drepper, C., Eichler, E.E., Alkan, C., Abdullaev, Z., Pack, S.D., Dutra, A., Pak, E., Hardy, J., Singleton, A., Williams, N.M., Heutink, P., Pickering-Brown, S., Morris, H.R., Tienari, P.J., Traynor, B.J., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72 (2011), 257–268.
251. Rintala, J., Jaatinen, P., Kiianmaa, K., Riikonen, J., Kemppainen, O., Sarviharju, M., Hervonen, A., Dose-dependent decrease in glial fibrillary acidic protein-immunoreactivity in rat cerebellum after lifelong ethanol consumption. Alcohol 23 (2001), 1–8.
252. Rodriguez-Arellano, J.J., Parpura, V., Zorec, R., Verkhratsky, A., Astrocytes in physiological aging and Alzheimer's disease. Neuroscience, 2015, 10.1016/j.neuroscience.2015.01.007.
253. Rodriguez, J.J., Olabarria, M., Chvatal, A., Verkhratsky, A., Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 16 (2009), 378–385.
254. Rodriguez, J.J., Terzieva, S., Olabarria, M., Lanza, R.G., Verkhratsky, A., Enriched environment and physical activity reverse astrogliodegeneration in the hippocampus of AD transgenic mice. Cell Death Dis., 4, 2013, e678.
255. Rojas, D.C., The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J. Neural Transm. 121 (2014), 891–905.
256. Rose, C.F., Verkhratsky, A., Parpura, V., Astrocyte glutamine synthetase: pivotal in health and disease. Biochem. Soc. Trans. 41 (2013), 1518–1524.
257. Rose, C.R., Karus, C., Two sides of the same coin: sodium homeostasis and signaling in astrocytes under physiological and pathophysiological conditions. Glia 61 (2013), 1191–1205.
258. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993), 59–62.
259. Roslin, M., Henriksson, R., Bergstrom, P., Ungerstedt, U., Bergenheim, A.T., Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J. Neurooncol. 61 (2003), 151–160.
260. Rossi, D., Brambilla, L., Valori, C.F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D.E., Volterra, A., Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15 (2008), 1691–1700.
261. Roth, T.L., Nayak, D., Atanasijevic, T., Koretsky, A.P., Latour, L.L., McGavern, D.B., Transcranial amelioration of inflammation and cell death after brain injury. Nature 505 (2014), 223–228.
262. Roze, E., Saudou, F., Caboche, J., Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr. Opin. Neurol. 21 (2008), 497–503.
263. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H., Glass, C.K., A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 (2009), 47–59.
264. Sanacora, G., Banasr, M., From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol. Psychiatry 73 (2013), 1172–1179.
265. Sari, Y., Sreemantula, S.N., Lee, M.R., Choi, D.S., Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats. J. Mol. Neurosci. 51 (2013), 779–787.
266. Sathe, K., Maetzler, W., Lang, J.D., Mounsey, R.B., Fleckenstein, C., Martin, H.L., Schulte, C., Mustafa, S., Synofzik, M., Vukovic, Z., Itohara, S., Berg, D., Teismann, P., S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain 135 (2012), 3336–3347.
267. Sayre, N.L., Chen, Y., Sifuentes, M., Stoveken, B., Lechleiter, J.D., Purinergic receptor stimulation decreases ischemic brain damage by energizing astrocyte mitochondria. Parpura, V., Verkhratsky, A., (eds.) Glutamate and ATP at the Interface of Metabolism and Signaling in the Brain, 2014, Springer, Cham/Heidelberg/New York/Dordrecht/London, 121–150.
268. Schitine, C., Nogaroli, L., Costa, M.R., Hedin-Pereira, C., Astrocyte heterogeneity in the brain: from development to disease. Front. Cell Neurosci., 9, 2015, 76.
269. Schmitt, A., Steyskal, C., Bernstein, H.G., Schneider-Axmann, T., Parlapani, E., Schaeffer, E.L., Gattaz, W.F., Bogerts, B., Schmitz, C., Falkai, P., Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol. 117 (2009), 395–407.
270. Schnieder, T.P., Dwork, A.J., Searching for neuropathology: gliosis in schizophrenia. Biol. Psychiatry 69 (2011), 134–139.
271. Scholl, U.I., Choi, M., Liu, T., Ramaekers, V.T., Hausler, M.G., Grimmer, J., Tobe, S.W., Farhi, A., Nelson-Williams, C., Lifton, R.P., Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 5842–5847.
272. Schwarcz, R., Hunter, C.A., Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?. Schizophr. Bull. 33 (2007), 652–653.
273. Scofield, M.D., Boger, H.A., Smith, R.J., Li, H., Haydon, P.G., Kalivas, P.W., Gq-DREADD selectively initiates glial glutamate release and inhibits cue-induced cocaine seeking. Biol. Psychiatry 78 (2015), 441–451.
274. Selkoe, D.J., Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001), 741–766.
275. Sequeira, A., Mamdani, F., Ernst, C., Vawter, M.P., Bunney, W.E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., Rouleau, G.A., Mechawar, N., Turecki, G., Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE, 4, 2009, e6585.
276. Shan, D., Lucas, E.K., Drummond, J.B., Haroutunian, V., Meador-Woodruff, J.H., McCullumsmith, R.E., Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr. Res. 144 (2013), 1–8.
277. Shan, D., Mount, D., Moore, S., Haroutunian, V., Meador-Woodruff, J.H., McCullumsmith, R.E., Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia. Schizophr. Res. 154 (2014), 1–13.
278. Shan, D., Yates, S., Roberts, R.C., McCullumsmith, R.E., Astroglia and severe mental illness: a role for glutamate microdomains. Parpura, V., Verkhratsky, A., (eds.) Pathological Potential of Neuroglia: Possible New Targets for Medical Intervention, 2014, Springer, New York/Heidelberg/Dordrecht/London, 373–395.
279. Shin, J.Y., Fang, Z.H., Yu, Z.X., Wang, C.E., Li, S.H., Li, X.J., Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol. 171 (2005), 1001–1012.
280. Siddiqui, A., Mallajosyula, J.K., Rane, A., Andersen, J.K., Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression. Neurobiol. Dis. 43 (2011), 527–532.
281. Simpson, J.E., Ince, P.G., Lace, G., Forster, G., Shaw, P.J., Matthews, F., Savva, G., Brayne, C., Wharton, S.B., Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 31 (2010), 578–590.
282. Singhrao, S.K., Thomas, P., Wood, J.D., MacMillan, J.C., Neal, J.W., Harper, P.S., Jones, A.L., Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington's, Alzheimer's, and Pick's diseases. Exp. Neurol. 150 (1998), 213–222.
283. Skuja, S., Groma, V., Smane, L., Alcoholism and cellular vulnerability in different brain regions. Ultrastruct. Pathol. 36 (2012), 40–47.
284. Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegalinski, E., Pera, J., Filip, M., Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol. Rep. 67 (2015), 569–580.
285. Sofroniew, M.V., Reactive astrocytes in neural repair and protection. Neuroscientist 11 (2005), 400–407.
286. Sofroniew, M.V., Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32 (2009), 638–647.
287. Song, P., Zhao, Z.Q., The involvement of glial cells in the development of morphine tolerance. Neurosci. Res. 39 (2001), 281–286.
288. Song, Y.J., Halliday, G.M., Holton, J.L., Lashley, T., O'Sullivan, S.S., McCann, H., Lees, A.J., Ozawa, T., Williams, D.R., Lockhart, P.J., Revesz, T.R., Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J. Neuropathol. Exp. Neurol. 68 (2009), 1073–1083.
289. Sosunov, A.A., Guilfoyle, E., Wu, X., McKhann, G.M. 2nd, Goldman, J.E., Phenotypic conversions of “protoplasmic” to “reactive” astrocytes in Alexander disease. J. Neurosci. 33 (2013), 7439–7450.
290. Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D., The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39 (2003), 43–56.
291. Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J.C., Williams, K.L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J.D., Leigh, P.N., Al-Chalabi, A., Miller, C.C., Nicholson, G., Shaw, C.E., TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008), 1668–1672.
292. Sriram, K., Benkovic, S.A., Hebert, M.A., Miller, D.B., O'Callaghan, J.P., Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?. J. Biol. Chem. 279 (2004), 19936–19947.
293. Steinhauser, C., Grunnet, M., Carmignoto, G., Crucial role of astrocytes in temporal lobe epilepsy. Neuroscience, 2015, 10.1016/j.neuroscience.2014.12.047.
294. Stenovec, M., Milosevic, M., Petrusic, V., Potokar, M., Stevic, Z., Prebil, M., Kreft, M., Trkov, S., Andjus, P.R., Zorec, R., Amyotrophic lateral sclerosis immunoglobulins G enhance the mobility of Lysotracker-labelled vesicles in cultured rat astrocytes. Acta Physiol. (Oxf.) 203 (2011), 457–471.
295. Stenzel, W., Soltek, S., Schluter, D., Deckert, M., The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis. J. Neuropathol. Exp. Neurol. 63 (2004), 631–640.
296. Stiles, C.D., Rowitch, D.H., Glioma stem cells: a midterm exam. Neuron 58 (2008), 832–846.
297. Struys-Ponsar, C., Guillard, O., van den Bosch de Aguilar, P., Effects of aluminum exposure on glutamate metabolism: a possible explanation for its toxicity. Exp. Neurol. 163 (2000), 157–164.
298. Suarez-Fernandez, M.B., Soldado, A.B., Sanz-Medel, A., Vega, J.A., Novelli, A., Fernandez-Sanchez, M.T., Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res. 835 (1999), 125–136.
299. Suarez, I., Bodega, G., Ramos, J.A., Fernandez-Ruiz, J.J., Fernandez, B., Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra-hydrocannabinol in the rat substantia nigra. Dev. Neurosci. 22 (2000), 253–263.
300. Sun, J.D., Liu, Y., Yuan, Y.H., Li, J., Chen, N.H., Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 37 (2012), 1305–1320.
301. Takano, T., Lin, J.H., Arcuino, G., Gao, Q., Yang, J., Nedergaard, M., Glutamate release promotes growth of malignant gliomas. Nat. Med. 7 (2001), 1010–1015.
302. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., Okuyama, S., Kawashima, N., Hori, S., Takimoto, M., Wada, K., Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997), 1699–1702.
303. Tang, G., Xu, Z., Goldman, J.E., Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J. Biol. Chem. 281 (2006), 38634–38643.
304. Terry, R.D., Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59 (2000), 1118–1119.
305. Tidyman, W.E., Rauen, K.A., The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 19 (2009), 230–236.
306. Tong, X., Ao, Y., Faas, G.C., Nwaobi, S.E., Xu, J., Haustein, M.D., Anderson, M.A., Mody, I., Olsen, M.L., Sofroniew, M.V., Khakh, B.S., Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat. Neurosci. 17 (2014), 694–703.
307. Traynelis, S.F., Dingledine, R., Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J. Neurophysiol. 59 (1988), 259–276.
308. Valori, C.F., Brambilla, L., Rossi, D., Amyotrophic lateral sclerosis: a glial perspective. Parpura, V., Verkhratsky, A., (eds.) Pathological Potential of Neuroglia. Possible New Targets for Medical Intervention, 2014, Springer, New York/Heidelberg/Dordrecht/London, 231–264.
309. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., Ganesalingam, J., Williams, K.L., Tripathi, V., Al-Saraj, S., Al-Chalabi, A., Leigh, P.N., Blair, I.P., Nicholson, G., de Belleroche, J., Gallo, J.M., Miller, C.C., Shaw, C.E., Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323 (2009), 1208–1211.
310. Vargas, M.R., Johnson, D.A., Sirkis, D.W., Messing, A., Johnson, J.A., Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 28 (2008), 13574–13581.
311. Verkhratsky, A., Butt, A.M., Glial Physiology and Pathophysiology. 2013, Wiley-Blackwell, Chichester.
312. Verkhratsky, A., Marutle, A., Rodriguez-Arellano, J.J., Nordberg, A., Glial asthenia and functional paralysis: a new perspective on neurodegeneration and Alzheimer's disease. Neuroscientist, 2014, 10.1177/1073858414547132.
313. Verkhratsky, A., Nedergaard, M., Astroglial cradle in the life of the synapse. Philos. Trans. R. Soc. Lond. B: Biol. Sci., 369, 2014, 20130595.
314. Verkhratsky, A., Olabarria, M., Noristani, H.N., Yeh, C.Y., Rodriguez, J.J., Astrocytes in Alzheimer's disease. Neurotherapeutics 7 (2010), 399–412.
315. Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., Sofroniew, M., Glia in the pathogenesis of neurodegenerative diseases. Biochem. Soc. Trans. 42 (2014), 1291–1301.
316. Verkhratsky, A., Reyes, R.C., Parpura, V., TRP channels coordinate ion signalling in astroglia. Rev. Physiol. Biochem. Pharmacol. 166 (2014), 1–22.
317. Verkhratsky, A., Rodriguez, J.J., Parpura, V., Astroglia in neurological diseases. Fut. Neurol. 8 (2013), 149–158.
318. Verkhratsky, A., Rodriguez, J.J., Steardo, L., Astrogliopathology: a central element of neuropsychiatric diseases?. Neuroscientist 20 (2014), 576–588.
319. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., Richardson, E.P. Jr., Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985), 559–577.
320. v1.2 gene in astrocytes in primary cultures and in the in vivo brain. Acta Physiol. (Oxf.) 214 (2015), 261–274.
321. Wang, L., Gutmann, D.H., Roos, R.P., Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 20 (2011), 286–293.
322. Wang, Y., Zaveri, H.P., Lee, T.S., Eid, T., The development of recurrent seizures after continuous intrahippocampal infusion of methionine sulfoximine in rats: a video-intracranial electroencephalographic study. Exp. Neurol. 220 (2009), 293–302.
323. Weber, M., Scherf, N., Kahl, T., Braumann, U.D., Scheibe, P., Kuska, J.P., Bayer, R., Buttner, A., Franke, H., Quantitative analysis of astrogliosis in drug-dependent humans. Brain Res. 1500 (2013), 72–87.
324. Webster, M.J., Knable, M.B., Johnston-Wilson, N., Nagata, K., Inagaki, M., Yolken, R.H., Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav. Immun. 15 (2001), 388–400.
325. Weng, Y.C., Kriz, J., Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia. Exp. Neurol. 204 (2007), 433–442.
326. Wilhelmsson, U., Eliasson, C., Bjerkvig, R., Pekny, M., Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression. Oncogene 22 (2003), 3407–3411.
327. Wilson, J.X., Peters, C.E., Sitar, S.M., Daoust, P., Gelb, A.W., Glutamate stimulates ascorbate transport by astrocytes. Brain Res. 858 (2000), 61–66.
328. Wise, D.R., Thompson, C.B., Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35 (2010), 427–433.
329. Wisniewski, K.E., Wisniewski, H.M., Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17 (1985), 278–282.
330. Wu, C.H., Fallini, C., Ticozzi, N., Keagle, P.J., Sapp, P.C., Piotrowska, K., Lowe, P., Koppers, M., McKenna-Yasek, D., Baron, D.M., Kost, J.E., Gonzalez-Perez, P., Fox, A.D., Adams, J., Taroni, F., Tiloca, C., Leclerc, A.L., Chafe, S.C., Mangroo, D., Moore, M.J., Zitzewitz, J.A., Xu, Z.S., van den Berg, L.H., Glass, J.D., Siciliano, G., Cirulli, E.T., Goldstein, D.B., Salachas, F., Meininger, V., Rossoll, W., Ratti, A., Gellera, C., Bosco, D.A., Bassell, G.J., Silani, V., Drory, V.E., Brown, R.H. Jr., Landers, J.E., Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488 (2012), 499–503.
331. Xia, M., Abazyan, S., Jouroukhin, Y., Pletnikov, M., Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. Schizophr. Res., 2014, 10.1016/j.schres.2014.10.044.
332. Yamanaka, K., Chun, S.J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D.H., Takahashi, R., Misawa, H., Cleveland, D.W., Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11 (2008), 251–253.
333. Yang, F.Y., Lee, Y.S., Cherng, C.G., Cheng, L.Y., Chang, W.T., Chuang, J.Y., Kao, G.S., Yu, L., D-Cycloserine, sarcosine and D-serine diminish the expression of cocaine-induced conditioned place preference. J. Psychopharmacol. 27 (2013), 550–558.
334. Yang, Y., Hentati, A., Deng, H.X., Dabbagh, O., Sasaki, T., Hirano, M., Hung, W.Y., Ouahchi, K., Yan, J., Azim, A.C., Cole, N., Gascon, G., Yagmour, A., Ben-Hamida, M., Pericak-Vance, M., Hentati, F., Siddique, T., The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29 (2001), 160–165.
335. Ye, Z.C., Sontheimer, H., Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 59 (1999), 4383–4391.
336. Yeh, C.Y., Vadhwana, B., Verkhratsky, A., Rodriguez, J.J., Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro 3 (2011), 271–279.
337. Yeh, C.Y., Verkhratsky, A., Terzieva, S., Rodriguez, J.J., Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological progression. Biogerontology 14 (2013), 777–787.
338. Yin, Z., Milatovic, D., Aschner, J.L., Syversen, T., Rocha, J.B., Souza, D.O., Sidoryk, M., Albrecht, J., Aschner, M., Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Res. 1131 (2007), 1–10.
339. Zamanian, J.L., Xu, L., Foo, L.C., Nouri, N., Zhou, L., Giffard, R.G., Barres, B.A., Genomic analysis of reactive astrogliosis. J. Neurosci. 32 (2012), 6391–6410.
340. Zeidan-Chulia, F., Salmina, A.B., Malinovskaya, N.A., Noda, M., Verkhratsky, A., Moreira, J.C., The glial perspective of autism spectrum disorders. Neurosci. Biobehav. Rev. 38 (2014), 160–172.
341. Zhang, L., Li, L., Wang, B., Qian, D.M., Song, X.M., Hu, M., Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. Neuroreport 24 (2013), 526–535.
342. Zhang, L., Li, L., Wang, B., Qian, D.M., Song, X.X., Hu, M., HCMV induces dysregulation of glutamate uptake and transporter expression in human fetal astrocytes. Neurochem. Res. 39 (2014), 2407–2418.
343. Zhang, Y., Jin, Y., Behr, M.J., Feustel, P.J., Morrison, J.P., Kimelberg, H.K., Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia. Exp. Neurol. 196 (2005), 41–46.
344. Zhao, Y., Rempe, D.A., Targeting astrocytes for stroke therapy. Neurotherapeutics 7 (2010), 439–451.
345. Zheng, Z., Diamond, M.I., Huntington disease and the huntingtin protein. Prog. Mol. Biol. Transl. Sci. 107 (2012), 189–214.
346. Zlokovic, B.V., The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008), 178–201.
347. Zonta, M., Angulo, M.C., Gobbo, S., Rosengarten, B., Hossmann, K.A., Pozzan, T., Carmignoto, G., Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 6 (2003), 43–50.
348. 2+ as a signalling route. ASN Neuro, 4, 2012, e00080.